Table 2.

Overview of comparison between ChEIs and placebo for Alzheimer disease regarding to adverse events.

		Pooled results from FEM
Adverse events	Sample size	OR	95% CI
AEs from any cause	7819	1.38	1.25–1.53
Discontinued due to AEs	6202	1.47	1.21–1.80
Severe AEs	3720	1.25	0.86–1.81
Serious AEs (fatal or nonfatal)	7064	1.00	0.83–1.20
Any related AEs	3369	1.60	1.35–1.89
Deaths	4502	0.91	0.52–1.58

AEs, adverse events; FEM, fixed-effect model; OR, odds ratio.

The material of this article is original research. All data in this manuscript is available and transparent for readers.